BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27443614)

  • 1. Dynamics of Dengue Virus (DENV)-Specific B Cells in the Response to DENV Serotype 1 Infections, Using Flow Cytometry With Labeled Virions.
    Woda M; Friberg H; Currier JR; Srikiatkhachorn A; Macareo LR; Green S; Jarman RG; Rothman AL; Mathew A
    J Infect Dis; 2016 Oct; 214(7):1001-9. PubMed ID: 27443614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B Cell Responses during Secondary Dengue Virus Infection Are Dominated by Highly Cross-Reactive, Memory-Derived Plasmablasts.
    Priyamvada L; Cho A; Onlamoon N; Zheng NY; Huang M; Kovalenkov Y; Chokephaibulkit K; Angkasekwinai N; Pattanapanyasat K; Ahmed R; Wilson PC; Wrammert J
    J Virol; 2016 Jun; 90(12):5574-85. PubMed ID: 27030262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescently labeled dengue viruses as probes to identify antigen-specific memory B cells by multiparametric flow cytometry.
    Woda M; Mathew A
    J Immunol Methods; 2015 Jan; 416():167-77. PubMed ID: 25497702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower activation-induced T-cell apoptosis is related to the pathological immune response in secondary infection with hetero-serotype dengue virus.
    Yang W; Yan H; Ma Y; Yu T; Guo H; Kuang Y; Ren R; Li J
    Immunobiology; 2016 Mar; 221(3):432-9. PubMed ID: 26655144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary and Secondary Dengue Virus Infections Elicit Similar Memory B-Cell Responses, but Breadth to Other Serotypes and Cross-Reactivity to Zika Virus Is Higher in Secondary Dengue.
    Andrade P; Narvekar P; Montoya M; Michlmayr D; Balmaseda A; Coloma J; Harris E
    J Infect Dis; 2020 Jul; 222(4):590-600. PubMed ID: 32193549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired Antibody-Independent Immune Response of B Cells in Patients With Acute Dengue Infection.
    Upasani V; Vo HTM; Ung S; Heng S; Laurent D; Choeung R; Duong V; Sorn S; Ly S; Rodenhuis-Zybert IA; Dussart P; Cantaert T
    Front Immunol; 2019; 10():2500. PubMed ID: 31736948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower IgG somatic hypermutation rates during acute dengue virus infection is compatible with a germinal center-independent B cell response.
    Godoy-Lozano EE; Téllez-Sosa J; Sánchez-González G; Sámano-Sánchez H; Aguilar-Salgado A; Salinas-Rodríguez A; Cortina-Ceballos B; Vivanco-Cid H; Hernández-Flores K; Pfaff JM; Kahle KM; Doranz BJ; Gómez-Barreto RE; Valdovinos-Torres H; López-Martínez I; Rodriguez MH; Martínez-Barnetche J
    Genome Med; 2016 Feb; 8(1):23. PubMed ID: 26917418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell responses during primary and secondary dengue virus infections in humans.
    Mathew A; West K; Kalayanarooj S; Gibbons RV; Srikiatkhachorn A; Green S; Libraty D; Jaiswal S; Rothman AL
    J Infect Dis; 2011 Nov; 204(10):1514-22. PubMed ID: 21930609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dominant cross-reactive B cell response during secondary acute dengue virus infection in humans.
    Zompi S; Montoya M; Pohl MO; Balmaseda A; Harris E
    PLoS Negl Trop Dis; 2012; 6(3):e1568. PubMed ID: 22448292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approaches to Interrogating the Human Memory B-Cell and Memory-Derived Antibody Repertoire Following Dengue Virus Infection.
    Lyski ZL; Messer WB
    Front Immunol; 2019; 10():1276. PubMed ID: 31244836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-Cell Analysis of B Cell/Antibody Cross-Reactivity Using a Novel Multicolor FluoroSpot Assay.
    Hadjilaou A; Green AM; Coloma J; Harris E
    J Immunol; 2015 Oct; 195(7):3490-6. PubMed ID: 26320246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of cytotoxic T lymphocyte epitopes in dengue virus serotype 1.
    Duan Z; Guo J; Huang X; Liu H; Chen X; Jiang M; Wen J
    J Med Virol; 2015 Jul; 87(7):1077-89. PubMed ID: 25777343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal Analysis of Memory B and T Cell Responses to Dengue Virus in a 5-Year Prospective Cohort Study in Thailand.
    Sánchez-Vargas LA; Kounlavouth S; Smith ML; Anderson KB; Srikiatkhachorn A; Ellison DW; Currier JR; Endy TP; Mathew A; Rothman AL
    Front Immunol; 2019; 10():1359. PubMed ID: 31263466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cells naturally induced during dengue virus infection release soluble CD27, the plasma level of which is associated with severe forms of pediatric dengue.
    Castañeda DM; Salgado DM; Narváez CF
    Virology; 2016 Oct; 497():136-145. PubMed ID: 27467579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between magnitude of the virus-specific plasmablast response and disease severity in dengue patients.
    Garcia-Bates TM; Cordeiro MT; Nascimento EJ; Smith AP; Soares de Melo KM; McBurney SP; Evans JD; Marques ET; Barratt-Boyes SM
    J Immunol; 2013 Jan; 190(1):80-7. PubMed ID: 23203929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human monoclonal antibodies to neutralize all dengue virus serotypes using lymphocytes from patients at acute phase of the secondary infection.
    Setthapramote C; Sasaki T; Puiprom O; Limkittikul K; Pitaksajjakul P; Pipattanaboon C; Sasayama M; Leuangwutiwong P; Phumratanaprapin W; Chamnachanan S; Kusolsuk T; Jittmittraphap A; Asai A; Arias JF; Hirai I; Kuhara M; Okuno Y; Kurosu T; Ramasoota P; Ikuta K
    Biochem Biophys Res Commun; 2012 Jul; 423(4):867-72. PubMed ID: 22713454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dengue Virus Directly Stimulates Polyclonal B Cell Activation.
    Correa AR; Berbel AC; Papa MP; Morais AT; Peçanha LM; Arruda LB
    PLoS One; 2015; 10(12):e0143391. PubMed ID: 26656738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression profile of human peripheral blood mononuclear cell miRNA is altered by antibody-dependent enhancement of infection with dengue virus serotype 3.
    Jiang L; Sun Q
    Virol J; 2018 Mar; 15(1):50. PubMed ID: 29566761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody avidity following secondary dengue virus type 2 infection across a range of disease severity.
    Lau L; Green AM; Balmaseda A; Harris E
    J Clin Virol; 2015 Aug; 69():63-7. PubMed ID: 26209381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dengue Virus (DENV) Neutralizing Antibody Kinetics in Children After Symptomatic Primary and Postprimary DENV Infection.
    Clapham HE; Rodriguez-Barraquer I; Azman AS; Althouse BM; Salje H; Gibbons RV; Rothman AL; Jarman RG; Nisalak A; Thaisomboonsuk B; Kalayanarooj S; Nimmannitya S; Vaughn DW; Green S; Yoon IK; Cummings DA
    J Infect Dis; 2016 May; 213(9):1428-35. PubMed ID: 26704615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.